Trend Results : Sloan Kettering Cancer Center


Blog Post Results (1-20 of 56)

FILTER RESULTS

Richard J. O'Reilly, MD, Named The Society of Memorial Sloan Kettering's Inaugural Prize Winner for Groundbreaking Contributions in Pediatric Oncology

The Society of Memorial Sloan Kettering Cancer Center (MSK) has announced that Richard J. O'Reilly, MD, has been named the inaugural recipient of The Society of Memorial Sloan Kettering Prize. This new award recognizes an individual who has made outstanding contributions to the field of pediatric oncology.

Memorial Sloan Kettering Researcher's Promising Entrectinib Clinical Trial Data Highlighted at American Association for Cancer Research Annual Meeting

Encouraging clinical trial data from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year's American Association for Cancer Research (AACR) Annual Meeting press program and presented as part of the Precision Medicine Early Clinical Trial Plenary Session.

Incidence of diagnosed thyroid cancer may be leveling off

In a study published online by JAMA Otolaryngology-Head & Neck Surgery, Luc G. T. Morris, M.D., M.Sc., of Memorial Sloan Kettering Cancer Center, New York, and colleagues analyzed the incidence of thyroid cancer in the U.S. from 1983 to 2012. Show More Summary

Memorial Sloan Kettering Launches Teen and Young Adult Program and Opens The Lounge in Collaboration with Teen Cancer America and Who Cares

Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of its new Teen and Young Adult (TYA) Program, TYA??@??MSK, which will offer special services to MSK's TYA population. In tandem, MSK officially opened The Lounge,...Show More Summary

There’s a surprisingly simple reason why the US spent $3 billion on drugs that were never used

News flash: We're spending more money on certain drugs than we need to. But one reason for this may surprise you. In a new study in the medical journal the BMJ, researchers with the Memorial Sloan Kettering Cancer Center found that the...Show More Summary

HEALTH NEWS: Viral con foils drug-resistant microbes, may nix need for poop transplants. “The rese…

HEALTH NEWS: Viral con foils drug-resistant microbes, may nix need for poop transplants. “The researchers, led by immunologists at the Memorial Sloan Kettering Cancer Center, got started on the idea of harnessing a viral decoy knowing that such germs normally manipulate and prune the gut microbiome. The community of viruses that bustle in human guts—called […]

Miami Cancer Institute at Baptist Health South Florida Joins Memorial Sloan Kettering Cancer Alliance

Memorial Sloan Kettering Cancer Center (MSK) and Miami Cancer Institute at Baptist Health South Florida announce the beginning of a dynamic and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and the highest caliber of cancer care. Show More Summary

In lung cancer, not all HER2 alterations are created equal

A joint study by University of Colorado Cancer Center and Memorial Sloan Kettering Cancer Center published in the Journal of Thoracic Oncology shows two distinct causes of HER2 activation in lung cancer: mutation of the gene and amplification of the gene. Show More Summary

The Future of Outpatient Cancer Surgery Takes Shape with New, First-of-Its-Kind Facility

A major transformation is beginning in cancer surgery that will enable patients to go home within a day of undergoing a significant operation. The new Josie Robertson Surgery Center (JRSC), opened by Memorial Sloan Kettering, exemplifies that transformation: a patient-focused facility that leverages technology and highly trained clinical teams to provide optimal care.

Why the U.S. should pay Irish drug prices if Pfizer wants to pay Irish tax rates

This is a guest post by Dr. Peter B. Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York City. Last week, the drug giant Pfizer announced its plan to become an Irish drug company, moving its corporate headquarters abroad as part of a complex business maneuver […]

Reinventing Cancer Surgery--By Designing A Better Hospital Experience

Memorial Sloan Kettering's new $300 million cancer center focuses on the well-being of the patient—even as they move you through the process as quickly as possible. Picture a hospital: Bright lights, buzzing machines, crowded waiting rooms, and frazzled nurses. Show More Summary

Maryland Robot Will Attend School For Cancer-Stricken 10-Year-Old Girl

A robot is set to attend school for a 10-year-old girl with cancer and it will be in school for five weeks while she undergoes cancer treatment at Memorial Sloan Kettering Cancer Center in New York, a report from NBC Washington says....Show More Summary

Lawsuit Accuses Sloan Kettering of Delaying Gene Therapy for Rare Blood Disease

7 months agoHealth : NYTimes: Health

A father is battling Memorial Sloan Kettering Cancer Center over the rights to developing a gene therapy that he hopes could cure his son’s blood disease.

Study Examines Cancer-Care Outcomes Among US Hospitals

A new JAMA Oncology study from Memorial Sloan Kettering Cancer Center finds that risk-adjusted Medicare claims data -- without information about the cancer stage of individual patients -- may be sufficient to calculate the long-term survival rates at hospitals providing cancer care in the United States.

Cornell, Sloan Kettering Partner in $10M Cancer Center

Cornell University, in partnership with Memorial Sloan Kettering Cancer Center (MSKCC), is opening a new $10 million Center of Cancer Nanotechnology Excellence that brings together scientists, engineers, biologists and physicians to develop and translate new cancer care applications based on nanotechnology.

Academics received $55 million to serve on health care company boards in 2013

Craig B. Thompson leads one of the country's most prestigious cancer hospitals, Memorial Sloan Kettering Cancer Center in New York. But noticeably absent from his online biographical sketch is his position as a director of one of the world’s biggest pharmaceutical companies, Merck, where over the past four years, he's received more than $1 million to serve on […]

Memorial Sloan Kettering Cancer Center Researchers Publish Landmark "Basket Study"

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients' tumors rather than where their cancer originated.

Lehigh Valley Health Network to Join Memorial Sloan Kettering Cancer Alliance

Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer care.

Memorial Sloan Kettering pays $37 million for NJ property

Chambers Street Properties, a real estate investment trust, has sold a Montvale, N.J., property to a subsidiary of Memorial Sloan Kettering Cancer Center for $37 million. The 142,500-square-foot... To view the full story, click the title link.

Pereira & O’Dell Shares Survival Stories for Memorial Sloan Kettering

Pereira & O’Dell New York unveiled the next phase of its “More science. Less fear.” campaign for Memorial Sloan Kettering Cancer Center, which launched last September, marking the agency’s first effort for the client since winning agency of record duties in February, 2014. Show More Summary

Copyright © 2015 Regator, LLC